Target intelligence / Profile preview

Tumor-Specific Idiotype Protein

Molecular classification
Immunoglobulin, B-cell receptor, Neoantigen
01

Overview

The tumor-specific idiotype protein refers to the unique antigenic determinants (idiotypes, Id) present in the variable regions of immunoglobulin (Ig) molecules expressed by malignant B cells. These idiotypes serve as tumor-specific antigens and targets for active immunotherapy, distinguishing malignant cells from normal ones. Immunotherapies include monoclonal anti-idiotype antibodies and patient-specific vaccines made from recombinant or purified Id protein.

Other names
Tumor-specific Ig idiotypeIdiotypic proteinTumor-specific immunoglobulin idiotype
02

Mechanism of action

Stimulation of an immune response specifically directed at the unique Ig expressed on each patient's malignant B-cells, including induction of polyclonal antibody responses and activation of T helper cells.

03

Biological functions

Antigen bindingB-cell signalingTumor-specific antigen presentationImmune response induction
04

Disease associations

CancerB-cell lymphomaMultiple myeloma
05

Safety considerations

Tumor heterogeneityAntigenic driftManufacturing complexityPotential for immune escape
06

Interacting drugs

Monoclonal anti-idiotype antibodies

3 more in the full profile.

07

Biomarkers

Tumor-specific idiotype sequenceAnti-idiotype antibody titersT cell responses to idiotype

Beyond the preview

Go deeper on Tumor-Specific Idiotype Protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor-Specific Idiotype Protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call